Form 4: Myriad Genetics CFO Scott Leffler Reports Stock Transaction
SEC Form 4 Filing
Scott Leffler, CFO of Myriad Genetics, reports the withholding of shares to cover tax obligations related to vesting restricted stock units.
Summary
- On January 29, 2025, Scott J. Leffler, the Chief Financial Officer of Myriad Genetics Inc. (MYGN), had 12,230 shares of common stock withheld by the company to cover tax obligations.
- This transaction occurred at a price of $12.54 per share.
- Following the transaction, Leffler directly owns 152,445 shares of Myriad Genetics common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to tax withholding, indicating a neutral sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's alignment with shareholder interests.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it reflects routine tax obligations of a company executive.
Key Dates
| Date | Description |
|---|---|
| 01/29/2025 | Date of stock transaction (tax withholding). |
| 01/30/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.